source
- Trump announces nine new drug pricing agreements to align U.S. prices with peer nationsPresident Trump announced a new round of voluntary pricing agreements with nine additional pharmaceutical companies, adding to the 17 firms that have previously signed similar deals. The companies…
- Amgen faces FTC-backed lawsuit over patent-application purchase amid insurer disputeAmgen and a large health insurer are locked in a court fight over whether purchasing a drug patent application can be used to extend a monopoly on a medicine. The case is drawing attention because…